BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31408348)

  • 1. Identification of a Biomarker Panel for Early Detection of Lung Cancer Patients.
    Geary B; Walker MJ; Snow JT; Lee DCH; Pernemalm M; Maleki-Dizaji S; Azadbakht N; Apostolidou S; Barnes J; Krysiak P; Shah R; Booton R; Dive C; Crosbie PA; Whetton AD
    J Proteome Res; 2019 Sep; 18(9):3369-3382. PubMed ID: 31408348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum mass profile signature as a biomarker of early lung cancer.
    Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
    Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of the platelet proteome in patients with early-stage cancer.
    Sabrkhany S; Kuijpers MJE; Knol JC; Olde Damink SWM; Dingemans AC; Verheul HM; Piersma SR; Pham TV; Griffioen AW; Oude Egbrink MGA; Jimenez CR
    J Proteomics; 2018 Apr; 177():65-74. PubMed ID: 29432918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
    Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
    Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.
    Guergova-Kuras M; Kurucz I; Hempel W; Tardieu N; Kádas J; Malderez-Bloes C; Jullien A; Kieffer Y; Hincapie M; Guttman A; Csánky E; Dezso B; Karger BL; Takács L
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.010298. PubMed ID: 21947365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
    Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
    Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-depth comparative proteomic analysis of yeast proteome using iTRAQ and SWATH based MS.
    Basak T; Bhat A; Malakar D; Pillai M; Sengupta S
    Mol Biosyst; 2015 Aug; 11(8):2135-43. PubMed ID: 26099114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate serum biomarkers of childhood-onset growth hormone deficiency using SWATH-MS and feature selection.
    Ortea I; Ruiz-Sánchez I; Cañete R; Caballero-Villarraso J; Cañete MD
    J Proteomics; 2018 Mar; 175():105-113. PubMed ID: 29317355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry.
    Wu HY; Pan YY; Kopylov AT; Zgoda V; Ma MC; Wang CH; Su WC; Lai WW; Cheng PN; Liao PC
    Proteomics Clin Appl; 2020 Jul; 14(4):e1900095. PubMed ID: 32012456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next Generation Proteomics for Clinical Biomarker Detection Using SWATH-MS.
    Lin Q; Tan HT; Chung MCM
    Methods Mol Biol; 2019; 1977():3-15. PubMed ID: 30980318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
    Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
    J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
    Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry.
    Arnhard K; Gottschall A; Pitterl F; Oberacher H
    Anal Bioanal Chem; 2015 Jan; 407(2):405-14. PubMed ID: 25366975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery.
    Njoku K; Pierce A; Chiasserini D; Geary B; Campbell AE; Kelsall J; Reed R; Geifman N; Whetton AD; Crosbie EJ
    EBioMedicine; 2024 Apr; 102():105064. PubMed ID: 38513301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Acquisition and Data-Processing Parameters for Improved Proteomic Quantification by Sequential Window Acquisition of All Theoretical Fragment Ion Mass Spectrometry.
    Li S; Cao Q; Xiao W; Guo Y; Yang Y; Duan X; Shui W
    J Proteome Res; 2017 Feb; 16(2):738-747. PubMed ID: 27995803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.